Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.
about
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapiesAdvances in managing ankylosing spondylitisSpontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).Biological therapies for spondyloarthritis.Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis.Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Are Additional Tests Needed to Rule Out Axial Spondyloarthritis in Patients Ages 16-45 Years With Short-Duration Chronic Back Pain and Maximally One Spondyloarthritis Feature?The window of opportunity: a relevant concept for axial spondyloarthritis.[Tapering and termination of immunosuppressive treatment in spondyloarthritides (including psoriatic arthritis)].Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion.Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.The current standard of care and the unmet needs for axial spondyloarthritisDefining the target: clinical aims in axial spondyloarthritis
P2860
Q24186403-4E08E220-DFB5-4224-88C7-8999AA51673FQ26777084-98484AD7-55AD-4225-B542-5943F29532EDQ34201927-AEFDE8D0-52EE-46DA-BA1A-38D25E39988CQ34894874-DFD2DEFB-CE7C-44EA-956B-9A7F9C657A44Q38198090-AF4C32A2-A9B1-4A5C-AC30-6F6C7751BF3EQ38199786-E85841AC-5278-46DB-84ED-DA9933DEBC7DQ38217223-2DFB833E-0136-433F-8C7F-69385238E6D3Q38611064-9F33E836-AA83-47DF-A261-29537FC80959Q38723754-5B39790B-F2C9-4C0C-A93E-556E798B6EC3Q38914839-5B467C6D-E32F-4EDF-9099-ED610E4B271EQ38972623-B6C986E6-4E83-4072-B5F6-58E05DD175C1Q39909425-8B1BF104-E721-42AC-A047-4DD45A5DEC08Q40791296-7AF0A465-01D5-4FAC-B0CC-D9E77D811B39Q53544912-1934F895-5331-40AC-8248-9583F97849D3Q53602109-A9349737-6889-48CD-B9D2-38B6464AFB40Q54624586-E0835413-9BF3-406D-9824-A37BFD6A3F8EQ59134860-0ACAD16D-AB05-4ABC-8F9F-093FA862E817Q59134864-99392CC8-D7BE-42B4-9A3F-E6D7CB05085F
P2860
Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@en
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@nl
type
label
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@en
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@nl
prefLabel
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@en
Maintenance of biologic-free r ...... ollow-up study, INFAST Part 2.
@nl
P2093
P2860
P1476
Maintenance of biologic-free r ...... follow-up study, INFAST Part 2
@en
P2093
All INFAST Investigators
D Chitkara
J Lenaerts
J Wollenhaupt
L Myasoutova
M Rudwaleit
N Vastesaeger
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-203460
P407
P50
P577
2013-06-05T00:00:00Z